title: Lac-regulated system for generating adenovirus 5 vaccine vectors expressing cytolytic human immunodeficiency virus 1 genes.
abstract: Adenovirus (Ad) vectors have been developed as human immunodeficiency-1 (HIV-1) vaccine vectors because they consistently induce immune responses in preclinical animal models and human trials. Strong promoters and codon-optimization are often used to enhance vaccine-induced HIV-1 gene expression and immunogenicity. However, if the transgene is inherently cytotoxic in the cell line used to produce the vector, and is expressed at high levels, it is difficult to rescue a stable Ad HIV-1 vaccine vector. Therefore we hypothesized that generation of Ad vaccine vectors expressing cytotoxic genes, such as HIV-1 env, would be more efficient if expression of the transgene was down-regulated during Ad rescue. To test this hypothesis, a Lac repressor-operator system was applied to regulate expression of reporter luciferase and HIV-1 env transgenes during Ad rescue. The results demonstrate that during Ad rescue, constitutive expression of the Lac repressor in 293 cells reduced transgene expression levels to approximately 5% of that observed in the absence of regulation. Furthermore, Lac-regulation translated into more efficient Ad rescue compared to traditional 293 cells. Importantly, Ad vectors rescued with this system showed high levels of transgene expression when transduced into cells that lack the Lac repressor protein. The Lac-regulated system also facilitated the rescue of modified Ad vectors that have non-native receptor tropism. These tropism-modified Ad vectors infect a broader range of cell types than the unmodified Ad, which could increase their effectiveness as a vaccine vector. Overall, the Lac-regulated system described here (i) is backwards compatible with Ad vector methods that employ bacterial-mediated homologous recombination, (ii) is adaptable for the engineering of tropism-modified Ad vectors, and (iii) does not require co-expression of regulatory genes from the vector or the addition of exogenous chemicals to induce or repress transgene expression. This system therefore could facilitate the development of Ad-based vaccine candidates that otherwise would not be feasible to generate.
authors.affiliation: Emory Vaccine Center, Emory University, Atlanta, GA 30329, United States.
authors.forename: Chunxia
authors.initials: C
authors.lastname: Zhao
authors.forename: Charles Jefferson
authors.initials: CJ
authors.lastname: Crews
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Derdeyn
authors.forename: Jerry L
authors.initials: JL
authors.lastname: Blackwell
mesh_terms: D016915:AIDS Vaccines / Q000235:genetics* / Q000276:immunology; D000260:Adenoviruses, Human / Q000235:genetics*; D002460:Cell Line; D015870:Gene Expression; D005822:Genetic Vectors; D042822:Genomic Instability; D015497:HIV-1 / Q000235:genetics* / Q000276:immunology; D054298:Human Immunodeficiency Virus Proteins / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D007763:Lac Operon; D011401:Promoter Regions, Genetic
chemical_list: D016915:AIDS Vaccines; D054298:Human Immunodeficiency Virus Proteins